IP Verse

Adjuvant Treatment Of Her2-Positive Breast Cancer - EP3589661B1

PatentPatent Analysis

EP3589661

F HOFFMANN LA ROCHE
Application Number
EP18712044A
Filing Date
Feb 28, 2018
Status
Granted And Under Opposition
Sep 29, 2023
Grant Date
Nov 1, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2464725B2
EP3559248B2
EP2296728B2

Bibliography

The patent EP3589661B1 was granted to F Hoffmann LA Roche on Nov 1, 2023 following the initial filing on Feb 28, 2018 under the application number EP18712044A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MICHALSKI HUTTERAMNN & PARTNER PATENTANWALTE MBBAug 1, 2024ADMISSIBLE
ABEL & IMRAYJul 31, 2024ADMISSIBLE
LANYON OPPOSITIONSJul 31, 2024ADMISSIBLE
BRAND MURRAY FULLERJul 23, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents